The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A mechanistic role for cardiac myocyte apoptosis in heart failure
Open accessAbstract
Heart failure is a common, lethal condition whose pathogenesis is poorly understood. Recent studies have identified low levels of myocyte apoptosis (80-250 myocytes per 10(5) nuclei) in failing human hearts. It remains unclear, however, whether this cell death is a coincidental finding, a protective process, or a causal component in pathogenesis. Using transgenic mice that express a conditionally active caspase exclusively in the myocardium, we demonstrate that very low levels of myocyte apoptosis (23 myocytes per 10(5) nuclei, compared with 1.5 myocytes per 10(5) nuclei in controls) are sufficient to cause a lethal, dilated cardiomyopathy. Interestingly, these levels are four- to tenfold lower than those observed in failing human hearts. Conversely, inhibition of cardiac myocyte death in this murine model largely prevents the development of cardiac dilation and contractile dysfunction, the hallmarks of heart failure. To our knowledge, these data provide the first direct evidence that myocyte apoptosis may be a causal mechanism of heart failure, and they suggest that inhibition of this cell death process may constitute the basis for novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, inhibiting caspases can both reduce the occurrence of heart failure or slow its progression after MI (45, 131, 374, 383, 384) as well as improve contractile function (45).”
From Cardiac remodeling in obesity (2008) · cites this paper as [374]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C. G., McDowell, J., Paskind, M. P., Rodman, L., Salfeld, J. G., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90490-5 · Cited by 1,408
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,159
An Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
Caspase activation: The induced-proximity model
Salvesen, G. S., & Dixit, V. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10964 · Cited by 932
Controlling Signal Transduction with Synthetic Ligands
Spencer, D. M., Wandless, T. J., Schreiber, S. L., & Crabtree, G. R. (1993) · Science · doi:10.1126/science.7694365 · Cited by 845
Luo, W., Grupp, I. L., Harrer, J. M., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
Research works printed but not linked: 2
- Walter, 1989, Biotechniques., 7, 1065
- Li, 1997, Am. J. Physiol., 272, H2313
Cited by
Sorted by citations
Items 401–500 of 765
Yankey, G. K., Li, T., Kılıç, A., Cheng, G., Satpute, A., Savai, K., Li, S., Moainie, S. L., Prastein, D. J., Defillipi, C., et al. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.12.021 · Cited by 29
Chin, L., Hsu, Y., Hsu, S.-C., Chen, Y., Chang, Y., Huang, S., Tsai, C., & Lin, C. (2017) · Oncotarget · doi:10.18632/oncotarget.22964 · Cited by 31
Cardiomyocyte Cell Cycle Activation Ameliorates Fibrosis in the Atrium
Nakajima, H., Nakajima, H. O., Dembowsky, K., Pasumarthi, K. B. S., & Field, L. J. (2005) · Circulation Research · doi:10.1161/01.res.0000197783.70106.4a · Cited by 29
Nitric oxide and promotion of cardiac myocyte apoptosis
Andreka, P. G., Tran, T., Webster, K. A., & Bishopric, N. H. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000041847.63338.b8 · Cited by 28
Rabkin, S. W., & Klassen, S. S. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.10.007 · Cited by 28
Leptin, a mediator of cardiac damage associated with obesity
Martínez‐Martínez, E., Jurado-López, R., Cervantes-Escalera, P., Cachofeiro, V., & Miana, M. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0060 · Cited by 27
Update on Peripartum Cardiomyopathy
Cruz, M., Briller, J. E., & Hibbard, J. U. (2010) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2010.02.003 · Cited by 27
Vishnu, K. V., Ajeeshkumar, K. K., Chatterjee, N. S., Lekshmi, R. G. K., Sreerekha, P. R., Mathew, S., & Ravishankar, C. N. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0834-5 · Cited by 28
Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis
Sinha‐Hikim, I., Friedman, T. C., Falz, M., Chalfant, V., Hasan, M. K., Espinoza‐Derout, J., Lee, D. L., Sims, C., Tran, P. H., Mahata, S. K., et al. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2536-1 · Cited by 28
de Virginy, D. R. B. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-0234-x · Cited by 28
XUAN, Y.-H., Liu, S., Li, Y., Dong, J., Luo, J., Liu, T., Jin, Y., & Sun, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7344 · Cited by 28
Subbarao, R. B., Ok, S., Lee, S. H., Kang, D., Kim, E., Kim, J., & Sohn, J. (2018) · Cells · doi:10.3390/cells7100144 · Cited by 27
Köhler, D., Arnold, R., Loukanov, T., & Gorenflo, M. (2013) · Frontiers in Pediatrics · doi:10.3389/fped.2013.00037 · Cited by 27
Cardiomyocyte apoptosis in animal models of obesity
Trivedi, P. S., & Barouch, L. A. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0085-z · Cited by 27
Role of apoptosis in ventricular remodeling
Chandrashekhar, Y. (2005) · Current Heart Failure Reports · doi:10.1007/s11897-005-0003-5 · Cited by 27
Hu, H.-J., Jiang, Z., Qiu, J., Zhou, S., & Liu, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6238 · Cited by 27
Targeting survival signaling in heart failure
Morissette, M. R., & Rosenzweig, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.004 · Cited by 27
Zhou, Q., Hahn, J. K., Neupane, B., Aidery, P., Labeit, S., Gawaz, M., & Gramlich, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040723 · Cited by 25
Häuselmann, S. P., Rosc-Schlüter, B. I., Lorenz, V., Plaisance, I., Brink, M., Pfister, O., & Kuster, G. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.007 · Cited by 26
Patibandla, S., Jiang, J., & Shu, X. (2018) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2018.05.024 · Cited by 27
Huang, W., Zhang, Q., Qi, H., Shi, P., Song, C., Liu, Y., & Sun, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01268 · Cited by 26
Xing, N., Wang, Y., Wang, W., Zhong, R., Xia, T., Ding, Z., Yang, Y., Zhong, Y., & Shu, Z. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153288 · Cited by 26
Regulation of GADD153 induced by mechanical stress in cardiomyocytes
Cheng, W., Wang, B. W., & Shyu, K. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02193.x · Cited by 26
Nitric Oxide and Oxidative Stress in Cardiovascular Aging
Raju, S. V. Y., Barouch, L. A., & Hare, J. M. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.21.re4 · Cited by 27
Yarbrough, W. M., Mukherjee, R., Escobar, G. P., Sample, J. A., McLean, J. E., Dowdy, K. B., Hendrick, J. W., Gibson, W. C., Hardin, A. E., Mingoia, J. T., et al. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.08.012 · Cited by 25
Self-citationLiu, Z., Gao, Z., Zeng, L., Liang, Z., Zheng, D.-C., & Wu, X. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.728 · Cited by 25
Sarohi, V., Srivastava, S., & Basak, T. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9060174 · Cited by 26
Schoppet, M., Ruppert, V., Hofbauer, L. C., Henser, S., Al‐Fakhri, N., Christ, M., Pankuweit, S., & Maisch, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.136 · Cited by 25
Multimarker approach for heart failure management: Perspectives and limitations
Giannessi, D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.006 · Cited by 26
Therapeutic opportunities for cell cycle re-entry and cardiac regeneration
Regula, K. M., Rzeszutek, M., Baetz, D., Seneviratne, C., & Kirshenbaum, L. A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.003 · Cited by 25
Wang, H., Chen, H. H., Feng, B., Wang, X., He, X., Hu, R., Yin, M., Wang, W., Fu, W. E., & Xu, Z. (2014) · BMC Biotechnology · doi:10.1186/1472-6750-14-75 · Cited by 24
Ding, W. Q., Wang, B., Zhang, M., & Gu, Y. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438616 · Cited by 24
Su, B., & Mo, F. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.019 · Cited by 24
Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis
Latva‐Hirvelä, J., Kytö, V., Saraste, A., Eriksson, S., Vuorinen, T., Pettersson, K. S. I., & Saukko, P. J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02113.x · Cited by 24
Liu, Y., Jiao, R., Ma, Z., Liu, W., Wu, Q., Yang, Z., Li, F., Yuan, Y., Bian, Z., & Tang, Q. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3841 · Cited by 24
Petrovič, D. (2004) · Folia Biologica · doi:10.14712/fb2004050020058 · Cited by 25
Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro
Wang, W. C., Uen, Y., Chang, M., Cheah, K.-P., Li, J.-S., Yu, W., Lee, K.-C., Choy, C. S., & Hu, C. M. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-138 · Cited by 24
Piacentino, V., Milano, C. A., Bolanos, M. D., Schroder, J. N., Messina, E., Cockrell, A. S., Jones, E., Krol, A., Bursac, N., Mao, L., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.186 · Cited by 23
Biomineralization Induced by Stressed Nanobacteria
Sommer, A. P., Pretorius, A.-M., Kajander, E. O., & Oron, U. (2003) · Crystal Growth & Design · doi:10.1021/cg034121x · Cited by 24
Novel caspase‐suicide proteins for tamoxifen‐inducible apoptosis
Chu, Y., Senghaas, N., Köster, R. W., Wurst, W., & Kühn, R. (2008) · genesis · doi:10.1002/dvg.20426 · Cited by 25
Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy
Wang, J., Wang, F., Zhu, J., Song, M. L., An, J., & Li, W. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1066-6 · Cited by 23
Zhang, Y., Shen, T., Liu, B., Dai, D., Cai, J., Zhao, C., Du, L., Jia, N., & He, Q. W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493616 · Cited by 23
Jin, M., Xiao, Z., Zhang, S., Men, X., Li, X., Zhang, B., Zhou, T., Hsiao, C., & Liu, K. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.12.060 · Cited by 23
Kolpakov, M. A., Seqqat, R., Rafiq, K., Xi, H., Margulies, K. B., Libonati, J. R., Powell, P. C., Houser, S. R., Dell’Italia, L. J., & Sabri, A. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.016 · Cited by 23
Role of Apoptosis in Heart Failure
Grazette, L. P., & Rosenzweig, A. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.03.007 · Cited by 23
Bogazzi, F., Russo, D., Raggi, F., Ultimieri, F., Urbani, C., Gasperi, M., Bartalena, L., & Martino, E. (2008) · Endocrinology · doi:10.1210/en.2008-0346 · Cited by 23
Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction
Yu, P. F., Song, S., Zhang, X., Cui, S., Wei, G., Huang, Z., Zeng, L., Ni, T., & Sun, A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302482120 · Cited by 24
Li, C., Chen, Y.-H., Wang, Q., Hou, J.-W., Wang, H., Wang, Y., & Li, Y. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001020 · Cited by 22
Molecular imaging in heart failure
Shirani, J., & Dilsizian, V. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.12.004 · Cited by 22
Self-citationApoptosis-related factors p53, bcl-2 and the defects of force transmission in dilated cardiomyopathy
Tsipis, A., Athanassiadou, A. M., Athanassiadou, P. P., Kavantzas, N., Agrogiannis, G. D., & Patsouris, E. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.05.007 · Cited by 23
The ‘Open-Artery Hypothesis’: New Clinical and Pathophysiologic Insights
Abbate, A., Biondi‐Zoccai, G., Baldi, A., Trani, C., Biasucci, L. M., & Vetrovec, G. W. (2003) · Cardiology · doi:10.1159/000074813 · Cited by 22
Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology
Thompson, J. W., Wei, J., Appau, K. A., Wang, H., Yu, H., Spiga, M. G., Graham, R. M., & Webster, K. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136847 · Cited by 21
Alway, S. E., Morissette, M. R., & Siu, P. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00004-x · Cited by 22
Molecular mechanism and therapy application of necrosis during myocardial injury
Xu, T., Ding, W., Tariq, M., Wang, Y., Wan, Q., Li, M., & Wang, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13575 · Cited by 22
A novel human S10F‐Hsp20 mutation induces lethal peripartum cardiomyopathy
Liu, G., Gardner, G., Adly, G., Jiang, M., Cai, W., Lam, C. K., Alogaili, F., Robbins, N., Rubinstein, J., & Kranias, E. G. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13665 · Cited by 21
Intervention for apoptosis in cardiomyopathy
Yaoita, H., & Maruyama, Y. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9074-6 · Cited by 20
Gao, F., Han, Z.-Q., Zhou, X., Shi, R., Dong, Y., Jiang, T.-M., & Li, Y. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.551795 · Cited by 20
Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart
Sishi, B., Bester, D. J., Wergeland, A., Loos, B., Jonassen, A. K., van Rooyen, J., & Engelbrecht, A. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011106 · Cited by 20
Fiedler, L. R., Maifoshie, E., & Schneider, M. D. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00002-0 · Cited by 20
Li, H., Xing, Y., Yang, D., Tang, X., Lu, D., & Wang, H. (2018) · Shock · doi:10.1097/shk.0000000000001205 · Cited by 20
Beneficial Effect of Candesartan on Rat Diastolic Heart Failure
Wake, R., Kim‐Mitsuyama, S., Izumi, Y., Yoshida, K., Izumiya, Y., Yukimura, T., Shiota, M., Yoshiyama, M., Yoshikawa, J., & Iwao, H. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050160 · Cited by 20
Fortilin inhibits p53, halts cardiomyocyte apoptosis, and protects the heart against heart failure
Chunhacha, P., Pinkaew, D., Sinthujaroen, P., Bowles, D. E., & Fujise, K. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00692-w · Cited by 19
Treskatsch, S., Shakibaei, M., Feldheiser, A., Shaqura, M. A., Dehé, L., Roepke, T. K., Spies, C., Schäfer, M., & Mousa, S. A. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.067 · Cited by 20
Apoptosis of Glutamatergic Neurons Fails to Trigger a Neurogenic Response in the Adult Neocortex
Diaz, F., McKeehan, N., Kang, W., & Hébert, J. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5885-12.2013 · Cited by 18
ER stress-induced apoptosis: A novel therapeutic target in heart failure
Wang, J., Hu, X., & Jiang, H. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.118 · Cited by 19
Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload
Park, M., Vatner, S. F., Yan, L., Gao, S., Yoon, S., Lee, G. J. A., Xie, L., Kitsis, R. N., & Vatner, D. E. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0324-y · Cited by 19
Self-citationAyyappan, P., Palayyan, S. R., Rani, M. P., & Raghu, K. G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.114 · Cited by 19
miRNAs As Potential Molecular Targets in Heart Failure
Katz, M. G., Fargnoli, A. S., Williams, R. D., Kendle, A. P., Steuerwald, N., & Bridges, C. R. (2014) · Future Cardiology · doi:10.2217/fca.14.64 · Cited by 19
Cao, X., Zhu, N., Zhang, Y., Chen, Y., Zhang, J., Li, J., Hao, P., Gao, C., & Li, L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29474 · Cited by 19
Dubec, S. J., Aurora, R., & Zassenhaus, H. P. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0617 · Cited by 20
Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease
Biondi‐Zoccai, G., Abbate, A., Vasaturo, F., Scarpa, S., Santini, D., Leone, A. M., Parisi, Q., De‐Giorgio, F., Bussani, R., Silvestri, F., et al. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.07.001 · Cited by 19
Oxidative Stress and Antioxidant Strategies in Cardiovascular Disease
Belló‐Klein, A., Khaper, N., Llesuy, S., Vassallo, D. V., & Pantos, C. I. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/678741 · Cited by 19
Sex-Dependent Mechanisms of Cell Death Modalities in Cardiovascular Disease
Horvath, C. G., & Kararigas, G. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.09.015 · Cited by 17
Effects of levosimendan in experimental acute coxsackievirus myocarditis
Latva‐Hirvelä, J., Kytö, V., Saraste, A., Vuorinen, T., Levijoki, J. M., & Saukko, P. J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02202.x · Cited by 18
Rodriguez, J. S., Rueda, J. O. V., Salas, M. A., Becerra, R. V., Carlo, M. N. D., Said, M., Vittone, L., Rinaldi, G. J., Portiansky, E. L., Mundiña‐Weilenmann, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096400 · Cited by 20
Nanoyttria Attenuates isoproterenol-induced Cardiac Injury
Godugu, C., Kumari, P., & Khurana, A. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0223 · Cited by 18
Wei, J., Liu, J., Zhang, L., Zhu, Y., Li, X., Zhou, G., Zhao, Y., Sun, Z., & Zhou, X. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138790 · Cited by 19
Li, Y., Peng, J., Karim, M. R., & Wang, B. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220328161826 · Cited by 18
Gelpi, R. J., Park, M., Gao, S., Dhar, S. K., Vatner, D. E., & Vatner, S. F. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2010 · Cited by 18
Gesing, A., Masternak, M. M., Wang, F., Lewiñski, A., Karbownik‐Lewińska, M., & Bartke, A. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010202 · Cited by 18
Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
Singh, K., Gupta, A. R., Sarkar, A., Gupta, I., Rana, S., Sarkar, S., & Khan, S. M. (2020) · Scientific Reports · doi:10.1038/s41598-019-57379-7 · Cited by 18
von Harsdorf, R. (2004) · Circulation Research · doi:10.1161/01.res.0000143717.70275.8f · Cited by 18
Dadson, K., Thavendiranathan, P., Hauck, L., Grothe, D., Azam, M. A., Stanley-Hasnain, S., Mahiny-Shahmohammady, D., Si, D., Bokhari, M., Lai, P. F. H., et al. (2022) · CJC Open · doi:10.1016/j.cjco.2022.08.006 · Cited by 17
Introduction—cell death in heart failure
Kitsis, R. N., & Narula, J. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9080-3 · Cited by 17
Self-citationCardioprotective role of APIP in myocardial infarction through ADORA2B
Lim, B., Jung, K., Gwon, Y., Oh, J. G., Roh, J.-I., Hong, S.-H., Kho, C., Park, W.-J., Lee, H., Bae, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1746-3 · Cited by 19
Advance in circular RNA modulation effects of heart failure
Jiang, L., Wang, X., Zhan, X., Kang, S., Liu, H., Luo, Y., & Lin, L. (2020) · Gene · doi:10.1016/j.gene.2020.100036 · Cited by 17
Davies, B., d’Udekem, Y., Ukoumunne, O. C., Algar, E. M., Newgreen, D. F., & Brizard, C. P. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2008.06.037 · Cited by 17
Cardiac Adaptation to Volume Overload
Melenovský, V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5203-4_9 · Cited by 17
Protective effect of Rheum turkestanikum root against doxorubicin-induced toxicity in H9c2 cells
Hosseini, A., & Rajabian, A. (2016) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2016.02.004 · Cited by 17
Menon, B., Krishnamurthy, P., Kaverina, E., Johnson, J. N., Ross, R. S., Singh, M., & Singh, K. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0602-7 · Cited by 17
Cellular preservation therapy in acute myocardial infarction
Abbate, A., Biondi‐Zoccai, G., Tassell, B. W. V., & Baldi, A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00066.2009 · Cited by 17
Li, Y., Ji, Q., Wang, Z., Shen, L., & He, B. (2020) · PubMed Central · Cited by 16
Apoptosis and heart failure: The role of non-coding RNAs and exosomal non-coding RNAs
Li, K., Ma, L., Lü, Z., Yan, L., Chen, W., Wang, B., Xu, H., & Asemi, Z. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154669 · Cited by 16
Kumfu, S., Sripetchwandee, J., Thonusin, C., Sumneang, N., Maneechote, C., Arunsak, B., Chunchai, T., Oo, T. T., Kongkaew, A., Chattipakorn, S. C., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116727 · Cited by 16
NASH triggers cardiometabolic HFpEF in aging mice
Kucsera, D., Ruppert, M., Sayour, N. V., Tóth, V. É., Kovács, T., Hegedűs, Z. I., Onódi, Z., Fábián, A., Kovács, A. D., Radovits, T., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01153-9 · Cited by 18
Qiu, Q., Yang, L., Xiao, C., Li, C., Wang, Y., Yang, K., Suo, W., Li, Y., Chuo, W., Wei, Y., et al. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/571076 · Cited by 16
Beyond the Mammalian Heart: Fish and Amphibians as a Model for Cardiac Repair and Regeneration
Jewhurst, K., & McLaughlin, K. A. (2015) · Journal of Developmental Biology · doi:10.3390/jdb4010001 · Cited by 16
Cardiac molecular imaging to track left ventricular remodeling in heart failure
Shirani, J., Singh, A., Agrawal, S., & Dilsizian, V. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0620-2 · Cited by 16
Self-citationElnakish, M. T., Hassona, M. D. H., Alhaj, M. A., Moldovan, L., Janssen, P. M. L., Khan, M., & Hassanain, H. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042500 · Cited by 16
One Syndrome, Many Faces: A Unified Perspective on Heart Failure Phenotypes
PARASKEVAIDIS, I. A., Tsougos, E., & Kourek, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188960 · Cited by 16
Metadata
- Authors
- Wencker, D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., & Kitsis, R. N.
- Affiliations
- Albert Einstein College of Medicine (US)
- Yeshiva University (US)
- Pfizer (United States) (US)
- Corresponding author
- Kitsis, Richard N.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-05-15
- Volume
- 111
- Issue
- 10
- Pages
- 1497-1504
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC155051
- OpenAlex
- W2002958873
- Cited by
- 765
- References
- 29
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 27 · 2023: 18 · 2022: 31 · 2021: 18 · 2020: 31 · 2019: 23 · 2018: 28 · 2017: 32 · 2016: 35 · 2015: 28 · 2014: 45 · 2013: 30 · 2012: 42
- FWCI
- 32.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ariad Pharmaceuticals
- New York Academy of Medicine
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01-HL-61550, R01 HL-60665, R01HL061550, R01HL060665)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- cardiomyocyte apoptosis, heart failure, dilated cardiomyopathy, caspases, transgenic mice, myocardial cell death, contractile dysfunction, heart failure pathogenesis
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Heart Failure, Humans, Mice, Inbred C57BL, Mice, Transgenic, Myocardium, Organ Specificity, Recombinant Fusion Proteins, Tacrolimus, Apoptosis, Disease Progression, Transgenes, Dimerization, Caspases, Enzyme Activators, Tacrolimus Binding Proteins, Myocytes, Cardiac, Mice, Caspase 8, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review